Stockreport

Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) market cap dropped US$51m last week; Public companies bore the brunt [Yahoo! Finance]

Gyre Therapeutics, Inc.  (GYRE) 
PDF Significant control over Gyre Therapeutics by public companies implies that the general public has more power to influence management and governance-related decisions [Read more]